化学塞栓療法剤 - Blue Inn Biosciences, Incorporated

Title:

化学塞栓療法剤

Document Type and Number:

Japanese Patent JP7055820

Kind Code:

B2

Abstract:

Described herein is a chemoembolization therapy, which combines therapeutic effects of peripheral arterial occlusion with the local administration of an anti-cancer agent. A particle or microsphere occludes the arteries providing blood flow to the tumor, resulting in tumor oxygen deprivation. The anti-angiogenic agent is an anti-cancer drug, as described herein.

More Like This:

JP2019059732	PHARMACEUTICAL COMPOSITIONS CONTAINING DIMETHYL FUMARATE
WO/2001/056576	TRANSDERMAL THERAPEUTIC SYSTEM FOR THE ADMINISTRATION OF ZALEPLON
JP4815321	Spray-dried granules containing pranlukast and how to make them

Inventors:

Na, james
David Imagawa
Tucci, Fabio
Beaton, Graham
Labra, satish

Application Number:

JP2019565460A

Publication Date:

April 18, 2022

Filing Date:

May 25, 2018

Export Citation:

Click for automatic bibliography generation Help

Assignee:

Blue Inn Biosciences, Incorporated

International Classes:

A61K47/32; A61K9/127; A61K31/404; A61K31/44; A61K31/47; A61K31/53; A61K31/704; A61K47/54; A61L31/04; A61L31/16; A61P35/00

Domestic Patent References:

JP2015520233A
JP2013544278A

Foreign References:

CN103054802A

Other References:

Liposomal curcumin inhibits hypoxia-induced angiogenesis after transcatheter arterial embolization in VX2 rabbit liver tumors,OncoTargets and Therapy,2015年,Volume 2015:8,Pages 2601―2611
NEOVASCULAR TARGETING CHEMOTHERAPY: ENCAPSULATION OF PACLITAXEL IN CATIONIC LIPOSOMES IMPAIRS FUNCTIONAL TUMOR MICROVASCULATURE,Int. J. Cancer,2004年,110,Pages 117-124

Attorney, Agent or Firm:

Yoshiyuki Inaba
Toshifumi Onuki
Akihiko Eguchi
Kazuhiko Naito

Previous Patent: Methods and equipment for performing initial connections in wireless communication systems

Next Patent: Machine-developed lithographic printing plate original plate, lithographic printing plate manufactur...